首页> 外文期刊>OncoTargets and therapy >Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma
【24h】

Micro-ribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma

机译:喉癌微核糖核酸表达谱及生物信息学靶基因分析

获取原文
           

摘要

Abstract: Abnormal expression of micro-ribonucleic acid (miRNA) might be clinically valuable as a biomarker or treatment target in the early diagnosis, treatment, and prognosis of tumors. However, little is known concerning abnormal miRNA expression of laryngeal carcinoma, one of the most commonly encountered head and neck tumors. Microarray analysis was used to obtain miRNA-expression profiles of ten pairs of freshly frozen laryngeal carcinoma tissue and surrounding normal tissue specimens. Characteristic miRNAs that were significantly related to laryngeal carcinoma were identified. Verification was performed using an additional 32 pairs of samples. The expression of two miRNAs (miR-21-3p and miR-106b-3p) was upregulated in both microarray and quantitative real-time polymerase chain-reaction analyses, whereas the expression of six miRNAs (let-7f-5p, miR-10a-5p, miR-125a-5p, miR-144-3p, miR-195-5p, and miR-203) was downregulated. The decreased expression of let-7f-5p and miR-195-5p is a novel finding in head and neck cancer. The target genes of these miRNAs were also predicted through multiple software programs. The differential expression of miRNAs might be related to the early onset and development of laryngeal carcinoma, and may be exploited as new biomarkers and therapeutic targets in the treatment of laryngeal carcinoma.
机译:摘要:微核糖核酸(miRNA)的异常表达可能在肿瘤的早期诊断,治疗和预后中作为生物标志物或治疗靶标具有临床价值。然而,关于喉癌的miRNA异常表达,人们所知甚少,喉癌是最常见的头颈部肿瘤之一。使用微阵列分析获得了十对新鲜冷冻的喉癌组织和周围正常组织标本的miRNA表达谱。确定了与喉癌显着相关的特征性miRNA。使用另外的32对样品进行验证。在芯片和定量实时聚合酶链反应分析中,两个miRNA(miR-21-3p和miR-106b-3p)的表达均被上调,而六个miRNA(let-7f-5p,miR-10a)的表达则被上调。 -5p,miR-125a-5p,miR-144-3p,miR-195-5p和miR-203)下调。 let-7f-5p和miR-195-5p的表达降低是在头颈癌中的新发现。这些miRNA的靶基因还可以通过多种软件程序进行预测。 miRNA的差异表达可能与喉癌的早期发作和发展有关,并可能被用作喉癌治疗的新生物标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号